The magic words, which so far seem to have been largely justified from the Ph II trials and will hopefully continue to be true:
no side effects.
- Forums
- ASX - By Stock
- NEU
- Wider autism efficacy potential for nnz-2566
NEU
neuren pharmaceuticals limited
Add to My Watchlist
3.03%
!
$14.61

Wider autism efficacy potential for nnz-2566, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.61 |
Change
0.430(3.03%) |
Mkt cap ! $1.823B |
Open | High | Low | Value | Volume |
$14.36 | $14.75 | $14.36 | $7.714M | 528.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 581 | $14.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.63 | 1279 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 1599 | 14.630 |
8 | 751 | 14.620 |
8 | 1311 | 14.610 |
13 | 1628 | 14.600 |
5 | 1313 | 14.590 |
Price($) | Vol. | No. |
---|---|---|
14.650 | 8632 | 19 |
14.660 | 673 | 4 |
14.670 | 1255 | 9 |
14.680 | 1644 | 8 |
14.690 | 2080 | 7 |
Last trade - 14.53pm 10/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |